Home › Idiopathic Pulmonary Fibrosis › Michigan
Pag-aaral pangklinika para sa Idiopathic Pulmonary Fibrosis sa Michigan
7 pag-aaral para sa Idiopathic Pulmonary Fibrosis ang naghahanap ng mga kalahok sa mga site sa Michigan.
Mga Lungsod sa Michigan
Opisyal na teksto ng pag-aaral (English)
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Ann Arbor
- Research Site, Detroit
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Michigan, Ann Arbor
- Henry Ford Health, Novi
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Henry Ford Health, Detroit
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06968845Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- University of Michigan Health System - Ann Arbor /ID# 279994, Ann Arbor
- Henry Ford Hospital /ID# 277843, Detroit
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07230288Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Beaumont Hospital, Royal Oak, Royal Oak
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Henry Ford Health, Detroit
Nagre-recruitObservasyonal na pag-aaral
Edad 21 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Ann Arbor, MI, Ann Arbor
- WISPer Site in Detroit, MI, Detroit
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06967805Mula sa ClinicalTrials.gov, na-kuha noong Okt 7, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.